Site Search

Displaying results 381 - 390 of 893

‘We brought target binding kinetics to the international research community’ – an interview with the K4DD project coordinators

News | 11/02/2019 |

Success stories from projects

There is mounting evidence to suggest that the kinetics of the interaction between a drug and its target – target binding kinetics – has a strong influence on the clinical success of a drug. IMI’s K4DD project developed methods and tools to allow researchers to study drug-target ...

‘IMI really was transformative’ – an interview with the COMPACT project coordinators

News | 28/01/2019 |

Success stories from projects

Biological medicines, such as proteins and nucleic acids, can be much more efficient than traditional synthetic drugs. However, getting them to where they are needed in the body is a big challenge. IMI’s COMPACT project developed prototypes of new drug delivery systems ...

IMI Stakeholder Forum 2019

Event | 12/06/2019 | Brussels, Belgium

The IMI Stakeholder Forum 2019 took place on Wednesday 12 June in Brussels , Belgium. The theme was "Brain health and disease in the digital era - 2020 & beyond". Outputs The goal of this event was to explore ideas for IMI Call topics that converge around the brain health / ...

IMI was a catalyst for a process that would have taken much longer otherwise – an interview with the ADAPT-SMART project coordinators

News | 25/01/2019 |

Success stories from projects

Today’s paradigms of bringing innovation to patients are challenged by new developments, such as a growing patient demand for timely access to promising therapies. To address this, more adaptive drug pathways are needed and the ADAPT-SMART project set out to address that ...

86th Edition – January 2019

Newsletter Issue | January 2019

Table of contents:

Open access drug development tools feature in new IMI Call for proposals

News | 22/01/2019 |

Press releases

Brussels, Belgium, 22 January 2019 – New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of the Call is over EUR 80 million. Half of this comes from the ...

IMI2 - Call 17

Content | 16/01/2019

IMI2 - Call 17 was launched on 22 January 2019 with the following topics: Optimising future obesity treatment Open access chemogenomics library and chemical probes for the druggable genome Intelligent prediction and identification of environmental risks posed by human medicinal ...

In memoriam: Antoine Cuvillier (1964 – 2018)

News | 11/01/2019 |

Press releases

It is with great sadness that we announce the death of our friend and colleague, Antoine Cuvillier, who passed away on 22 December 2018 at the age of 54. Antoine was IMI’s Head of Administration and Finance. After studying law in France and the US, Antoine embarked on a career ...

ESCulab

Project| Ongoing | IMI2 |
Target identification
Drug discovery

European screening centre; unique library for attractive biology

NECESSITY

Project| Ongoing | IMI2 |
Autoimmune diseases
Tools for predicting/monitoring efficacy
Clinical trial design
Disease taxonomy

New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients